Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.
Type:
Grant
Filed:
April 20, 2010
Date of Patent:
March 19, 2019
Assignee:
CRYXA LLC
Inventors:
F. Joseph Daugherty, John R. Palmer, Michael S. Tempesta
Abstract: An oral creatine formulation includes soluble creatine and polyethylene glycol, coated with an enteric coating. The most preferred soluble creatine is creatine HCl. The most preferred polyethylene glycols have an average molecular weight of from 3150 to 3685, although for particular formulation formulations and particular uses, the average molecular weight polyethylene glycols may range from 190 to 9000.
Type:
Grant
Filed:
April 20, 2010
Date of Patent:
March 12, 2019
Assignee:
CRYXA LLC
Inventors:
F. Joseph Daugherty, John R. Palmer, Jr., Michael S. Tempesta
© 2024 Justia
